Target intelligence / Profile preview

Immunoglobulin lambda variable 3-7 (IGLV3-7)

Target
IGLV3-7
Molecular classification
Immunoglobulin variable region, Immunoglobulin gene family, Other (not a receptor, transporter, enzyme, or classical signaling molecule)
01

Overview

Immunoglobulin lambda variable 3-7 is a gene encoding one of the variable domains of the immunoglobulin lambda light chain. This gene is located in the immunoglobulin lambda locus on chromosome 22q11.2 and encodes a segment that contributes to the antigen-binding site through V(D)J recombination in B cells. The lambda light chains are one of two types of immunoglobulin light chains in humans (the other being kappa), and their variable domains provide sequence diversity essential for the adaptive immune response. The IGLV3-7 gene, along with other IGLV genes, is part of a complex locus exhibiting high allelic variation, reflecting evolutionary adaptation to pathogens. IGLV3-7 is not a classical drug target, receptor, or enzyme—rather, it is a genomic element contributing to antibody diversity. Its role and importance are primarily within the scope of immunogenetics and antibody structure, rather than as a molecule intended for direct pharmacological modulation.

Other names
IGLV37V2-5PIGLV3-7
02

Mechanism of action

Not applicable (does not serve as a target for drugs or antibodies; its gene products are incorporated into the antigen recognition site of antibodies)

03

Biological functions

Antigen bindingImmune response (component of B cell receptors and antibodies)
04

Disease associations

Other (polymorphisms associated in rare cases with immune repertoire diversity, but not a direct disease target)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-7 (IGLV3-7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-7 (IGLV3-7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call